A link to the FDA's list of bulk drug substances it says may carry significant safety risks in compounding, relevant to the peptide policy fight.
Recap by typeshit. Post by William Lagakos on X.
Disposable pens for insulin, MS and weight loss drugs are reaching recycling centres, where workers could come into contact with them.
A short teaser points to another reported side effect of GLP-1 drugs but doesn't say what it is.
Martin cautions followers that peptides being simpler to obtain is no reason to use ones that haven't been tested much.
BuzzFeed's celebrity desk picks up a widely viewed post joking about a new GLP-1 side effect, following slang like Ozempic face. Details are thin.
Six peptides can now be compounded under strict conditions, but HHS itself says that proves nothing on safety, and research-use-only sellers stay outside the policy.
A repost points to a roundup of upcoming weight loss drugs, including ones that combine several hormone signals in a single treatment.
Loading…